Table 1.
Patients and disease characteristics in the entire population and according to adjuvant regimen
| Characteristic | Total (N = 109) | G based (N = 43) | A based (N = 66) | P* |
|---|---|---|---|---|
| N (%) | N (%) | N (%) | ||
| Center | 0.16 | |||
| INT | 78 (72) | 34 (79) | 44 (67) | |
| IEO | 31 (28) | 9 (21) | 22 (33) | |
| Age | 0.59 | |||
| Median | 50 | 49 | 52 | |
| IQR | 43–57 | 43–56 | 44–59 | |
| Stage | 0.59 | |||
| IA | 20 (19) | 7 (17) | 13 (21) | |
| IB | 83 (81) | 35 (83) | 48 (79) | |
| NA | 6 | 1 | 5 | |
| Mitotic index | 0.37 | |||
| Median | 21 | 25 | 16 | |
| IQR | 12–34 | 14–34 | 12–33 | |
| NA | 55 | 16 | 39 | |
| Surgery | 0.53 | |||
| LPT | 90 (88) | 34 (85) | 56 (90) | |
| LPS | 12 (12) | 6 (15) | 6 (10) | |
| NA | 7 | 3 | 4 | |
| Morcellation | 0.04 | |||
| No | 52 (72) | 15 (58) | 37 (80) | |
| Yes | 20 (28) | 11 (42) | 9 (20) | |
| NA | 37 | 17 | 20 | |
| Oophorectomy | 0.19 | |||
| No | 27 (27) | 13 (34) | 14 (22) | |
| Yes | 74 (73) | 25 (66) | 49 (78) | |
| NA | 8 | 5 | 3 | |
| RT | 0.05 | |||
| No | 98 (90) | 42 (98) | 56 (85) | |
| Yes | 11 (10) | 1 (2) | 10 (15) | |
*Chi-square test, Fisher exact test or Mann-Whitney U test as appropriate
INT Fondazione IRCCS Istituto Nazionale dei Tumori of Milan, IEO European Institute of Oncology, IQR interquartile range, G gemcitabine, A anthracycline, RT radiotherapy